Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06880692 · ClinicalTrials.gov registry record · NA
The Tick App: Changing Behaviors With Educational Messaging
A NA study of Tick Bites, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 3,500
- Enrollment target
- 4
- Study locations
NCT06880692: Recruiting NA study of Tick Bites, sponsored by University of Wisconsin, Madison.
NCT06880692 is a NA study of Tick Bites that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 3,500 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (149% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06880692, a NA study of Tick Bites, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,500 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this work is to evaluate the use of ecological momentary assessments as a tool to assess risk and risk factors for tick encounters and tick-borne diseases. This study will be conducted across the United States, with a focus the upper Midwest and Northeast and with a focus on Wisconsin and will enroll up to 1000 people.
Primary Outcome
A goal of the intervention is to see an increase in tick prevention behaviors (tick checks and showering). To measure this, the change in number of tick prevention behaviors will be compared between groups. Data collected when participant completes 7 daily logs in app within 12 months.
Conditions Studied
Interventions
- OTHER Educational Materials delivered via the Tick App
Study Locations (4)
Illinois
- University of Illinois - Urbana
Michigan
- Michigan State University - East Lansing
New York
- Columbia University - New York
Washington
- Washington State University - Pullman
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,500 participants |
| Start Date | 2020-03-31 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT06880692 shows while recruiting
NCT06880692 is an interventional study that assigns participants to a tested intervention. Its 3,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (149% higher).
The record links to 1 condition, with Tick Bites appearing as the primary indexed condition, and to 1 intervention - of which Educational Materials delivered via the Tick App is the first listed.
NCT06880692 reports a single indexed study location in Illinois, Michigan, New York.
Frequently Asked Questions
What is clinical trial NCT06880692 about?
NCT06880692 is a clinical study titled "The Tick App: Changing Behaviors With Educational Messaging". The goal of this work is to evaluate the use of ecological momentary assessments as a tool to assess risk and risk factors for tick encounters and tick-borne diseases. This study will be conducted across the United States, with a focus the upper Midwest and Northeast and with a focus on Wisconsin an...
What is the current status of trial NCT06880692?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,500 participants. The study started on 2020-03-31. Estimated completion is 2026-05.
What conditions does trial NCT06880692 study?
This clinical trial studies the following conditions: Tick Bites.
What interventions are being tested in trial NCT06880692?
The interventions under investigation include: Educational Materials delivered via the Tick App (OTHER).
Who is sponsoring clinical trial NCT06880692?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06880692 being conducted?
This trial has 4 study locations across Illinois, Michigan, New York, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tick Bites
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06880692's enrollment target sits among peer trials
3,500 36th of 2000 higher than 1,964 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI